🔎 Trials Near Me

Home › Anemia › Texas › Houston

Pag-aaral pangklinika para sa Anemia sa Houston, TX

Isang pag-aaral para sa Anemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Nagre-recruitPhase 1/2
  • MD Anderson, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05320198

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Nagre-recruitPhase 3
  • The University of Texas-MD Anderson Cancer Center - Leukemia Center, Houston
  • LUMI Research, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07422480

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

Nagre-recruitPhase 3
  • MD Anderson Cancer Center, Houston
  • The University of Utah-Huntsman Cancer Institute, Houston
  • LUMI Research, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07623161

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Nagre-recruitPhase 3
  • U.T. MD Anderson Cancer Center, Division of Cancer Medicine, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT06499285

A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency

Nagre-recruit
  • The University of Texas Health Science Center at Houston, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 30, 2025 · NCT05735314

Pag-aaral para sa Anemia sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.